General MedicationsINJECTIONStandard
DOCETAXEL
DOCETAXEL
Standard Dose
160MG/16ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: N/A Marketing status: Prescription
Summary
Approval overview DOCETAXEL is listed in Drugs@FDA under application 215813 (NDA).
Review priority: N/A Marketing status: Prescription Active ingredient DOCETAXEL Form and strength INJECTABLE;INJECTION - 160MG/16ML Sponsor AVYXA HOLDINGS Submission history Latest submission status date: 2025-01-17 00:00:00.
Structured Monograph
Clinical summary
Approval overview DOCETAXEL is listed in Drugs@FDA under application 215813 (NDA). Review priority: N/A Marketing status: Prescription Active ingredient DOCETAXEL Form and strength INJECTABLE;INJECTION - 160MG/16ML Sponsor AVYXA HOLDINGS Submission history Latest submission status date: 2025-01-17 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: N/A
Interaction Notes
- No interaction notes stored yet.